Aquestive Therapeutics Inc (AQST)
5.15
-0.37
(-6.70%)
USD |
NASDAQ |
Nov 04, 16:00
5.03
-0.12
(-2.33%)
After-Hours: 20:00
Aquestive Therapeutics Debt to Equity Ratio: -0.8464 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.8464 |
| March 31, 2024 | -0.7929 |
| December 31, 2023 | -0.2585 |
| September 30, 2023 | -0.3805 |
| June 30, 2023 | -0.3672 |
| March 31, 2023 | -0.3881 |
| December 31, 2022 | -0.4399 |
| September 30, 2022 | -0.4906 |
| June 30, 2022 | -0.556 |
| March 31, 2022 | -0.5824 |
| December 31, 2021 | -0.6523 |
| September 30, 2021 | -0.6695 |
| June 30, 2021 | -0.7294 |
| March 31, 2021 | -0.7347 |
| Date | Value |
|---|---|
| December 31, 2020 | -0.761 |
| September 30, 2020 | -1.700 |
| June 30, 2020 | -2.876 |
| March 31, 2020 | -2.925 |
| December 31, 2019 | -9.856 |
| September 30, 2019 | -1.735 |
| June 30, 2019 | -1.924 |
| March 31, 2019 | -7.859 |
| December 31, 2018 | 4.683 |
| September 30, 2018 | 1.996 |
| June 30, 2018 | -1.192 |
| March 31, 2018 | -2.014 |
| December 31, 2017 | -1.718 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-9.856
Minimum
Dec 2019
-0.2585
Maximum
Dec 2023
-1.369
Average
-0.6695
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals Inc | 0.00 |
| Rockwell Medical Inc | 0.3815 |
| Cormedix Inc | 0.00 |
| Geovax Labs Inc | -0.0616 |
| Myomo Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 117.60M |
| Total Liabilities (Quarterly) | 153.08M |
| Shareholders Equity (Quarterly) | -35.48M |
| Current Ratio | 7.486 |
| Net Debt Paydown Yield | 1.04% |